GROUP MEMBERS

• Muhammad Fayyaz
• Ayesha Gulzar
 PHARMACEUTICAL

A pharmaceutical is any kind of drug used for

medicinal purposes, like:
• Cough Syrup
• Sleeping pills etc.
 INTRODUCTION

❑ Growing rate of Pharmaceutical industry

❑ The global pharmaceutical market

❑ Competitive and challenging

❑ 600 Pharmaceutical companies

 HISTORY
➢1947 – Only 3 units located at Lahore, Rawalpindi and Peshawar
➢The discovery of antibiotics, tranquilizers etc changed all the dynamics and
Pakistan had to import these new expensive medicines from western
countries
➢Government suspended import license and encouraged local
manufacturing
➢By 1954, there were 15 pharmaceutical industrial units. The number
rose to 31 in the coming year and by 1960, Pakistan had 60 units.
TOP 30 COMPANIES OPERATING
IN PAKISTAN
 RANKINGS ON … DESCRIPTION |------------------------------- MONTHLY HIGHLIGHTS -------------------------------|
RK~MTH RK~QTR RK~MAT COR MTH ~ 11/2018 MTH ~11/2018 MTH ~11/2018 MAT ~ 11/2018 MAT ~11/2018
11/2018 11/2018 11/2018 P CORP DESC LC-Rs LC-Rs LC-Rs LC-Rs LC-Rs
RUPEES ABB RUPEES Rs + ~10/2018 Rs + ~11/2017 RUPEES Rs + ~11/2017

1 1 1 TOT SEL
SELECTED TOTAL 34,238,086,298 (4.66) 14.24 389,102,768,862 13.62
1 1 1 N NATIONAL 23,021,970,168 (6.21) 16.33 266,576,772,132 16.22
2 2 2 M MULTI-NATIONAL 11,216,116,130 (1.31) 10.18 122,525,996,730 8.37
1 1 1 GSK GLAXOSMITHKLINE 2,783,796,165 10.24 11.71 26,923,574,413 6.23
2 2 2 GTZ GETZ PHARMA 2,036,117,134 (5.38) 12.73 24,198,302,216 13.78
3 3 3 ABT ABBOTT LAB PAK LTD 1,940,596,212 (9.27) (0.10) 23,518,208,354 9.40
4 4 4 SAM SAMI 1,669,257,506 (11.36) 15.33 20,500,350,980 14.30
5 5 5 MD. MARTIN DOW LIMITED 1,286,037,497 (10.32) 8.48 16,155,015,885 14.52
6 6 6 SEA THE SEARLE COMPANY 1,194,832,693 (0.13) 12.39 14,551,500,406 14.58
7 8 7 HL. HILTON 1,142,169,557 2.29 30.13 12,431,301,141 23.18
8 7 8 HQI HIGH-Q INTL 1,066,532,552 (8.82) 25.75 12,185,444,992 25.77
9 10 11 B6H BOSCH 1,005,211,656 (3.92) 15.03 10,879,800,199 14.03
10 9 10 OB2 OBS 990,925,773 (11.05) 17.72 11,680,553,305 14.66
11 12 12 .GC GSK CONSUMER 978,193,850 (8.33) 9.46 10,077,463,622 -1.58
12 11 9 S.A SANOFI-AVENTIS PAK 934,944,399 (4.48) 5.91 11,978,265,335 12.58
13 13 13 PFC PFIZER INC 851,508,698 (4.41) 14.07 9,644,475,020 4.93
14 14 14 NV. NOVARTIS PH.PAK LT 804,956,958 0.41 10.37 8,839,605,169 -0.97
15 16 17 NES NESTLE PAKISTAN LT 763,395,892 3.88 34.59 7,813,777,978 38.30
16 15 16 AT3 ATCO 758,677,821 (0.27) 25.65 7,903,657,542 27.14
17 17 15 BGO BARRETT HODGSON 726,761,359 (4.60) 19.45 7,953,394,686 13.83
18 19 20 C.C CCL 657,825,604 1.86 35.91 6,088,068,938 21.09
19 18 18 HIG HIGHNOON 635,321,095 (5.41) 26.26 7,153,870,655 27.86
20 21 21 PV- PHARMEVO PVT. LTD. 540,637,700 (6.20) 10.43 6,082,433,017 11.74
21 20 22 MOG MORINAGA 532,536,891 (16.60) 86.18 5,680,607,429 67.71
22 22 19 BAY BAYER PAK PVT LTD 525,740,449 (7.99) 3.69 6,254,345,264 3.66
23 23 23 ICI I.C.I 447,991,902 0.75 16.16 5,079,123,461 15.62
24 24 24 MTR MACTER 396,043,452 (4.23) 8.00 4,586,748,078 23.51
25 29 30 N-N NOVO NORDISK 352,590,643 15.42 36.43 3,420,146,341 25.92
26 25 25 G1O GLOBAL PHARMA 348,611,677 (8.42) 11.72 4,290,769,188 5.73
27 26 26 LLY ELI LILLY 348,604,863 (3.01) 6.34 4,163,294,112 9.51
28 28 28 FZS FEROZSONS 321,617,924 (9.25) 0.78 4,056,791,822 6.86
29 27 27 IND INDUS 317,231,512 (13.98) 6.54 4,085,872,797 4.06
30 32 29 T9P TABROS PHARMA 292,478,999 (8.77) (0.67) 3,484,141,457 7.58
Therapeutic Class
 Segment Value % Share Growth
ANTIRHEUMATICS NON-S PLN 19,300,081,156 5.08 9.65
INFANTS MILKS 18,210,462,967 4.79 24.22
PROTON PUMP INHIBITORS 18,040,874,948 4.74 15.62
CEPHALOSPORINS INJECT 16,377,450,995 4.31 13.75
CEPHALOSPORINS ORAL 15,680,994,483 4.12 9.56
ORAL FLUOROQUINOLONES 12,900,455,663 3.39 5.57
NON-NARCOTIC ANALGESICS 11,065,381,593 2.91 6.77
BROAD SPECT PENICILL ORAL 10,570,052,338 2.78 3.83
MACROLIDES & SIMILAR TYPE 7,461,834,026 1.96 13.33
CALCIUM 6,745,596,275 1.77 13.75
ANTI-EPILEPTICS 6,576,565,605 1.73 14.76
DPP-IV INH & BIGUAN COMB 6,226,125,375 1.64 30.95
ANTIHISTAMINES SYSTEMIC 5,374,012,845 1.41 14.49
H INSUL+AN I- OR L-A+F-A 5,301,240,054 1.39 18.06
EXPECTORANTS 5,116,894,879 1.35 22.09
STATINS (HMG-COA RED) 4,880,933,765 1.28 15.34
VITAMIN B12 PLAIN 4,588,389,339 1.21 16.33
SULPHONYLUREA A-DIABS 4,439,203,615 1.17 12.85
HEPATITIS C ANTIVIRALS 4,373,559,127 1.15 -1.25
BETA BLOCKING AGENT PLAIN 4,331,941,507 1.14 10.85
* Others * % Share 0 50.68 0.00
2%
2% 2% ANTIRHEUMATICS NON-S PLN
3% 2%
3% 10% INFANTS MILKS
3% PROTON PUMP INHIBITORS
10%
3% CEPHALOSPORINS INJECT
3% CEPHALOSPORINS ORAL
4% 10%
ORAL FLUOROQUINOLONES
4%
4% NON-NARCOTIC ANALGESICS
9%
6% BROAD SPECT PENICILL ORAL
6% 8% MACROLIDES & SIMILAR TYPE
7%
CALCIUM
BENEFITS OF LOCAL PHARMAMANUFACTURING
SECTOR
PROBLEMS TO THE PHARMACEUTICAL INDUSTRY OF
PAKISTAN
 Lack of new
Technology

Lack of Trained
Manpower Higher Interest Rate

Difficulty in Export Terrorism

Unethical Practices in Pharma
Unethical Practices in Pharma

▪ Bribing
▪ Pick and Drop Services
▪ Payments of Utility Bills
▪ Heavy Discounts
▪ FOC Goods
▪ Checks/Cash incentives
▪ Expensive Lunch/Dinner
Unethical Practices in Pharma

▪ Free Medical Camps

▪ Monthly Salary

▪ Jewelry

▪ Furniture/Fixture

▪ Office Equipment

▪ Expensive Electronic Items

Unethical Practices

▪ Expensive Gifts

▪ Excursion Trips

▪ Vacation Packages

▪ Local and Foreign Trips

Unethical Practices

▪ Renovation of Clinic

▪ Partner ship offers

▪ Installment offers

▪ And other Services

Let Thy Food Be The Medicine
And Medicine Be Thy Food
Hippocrates